Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

Antonioli, E ; Guglielmelli, P ; Pancrazzi, A ; Bogani, C ; Verrucci, M ; Ponziani, V ; Longo, G ; Bosi, A ; Vannucchi, A M

England: Nature Publishing Group

Texto completo disponível

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

AOUDJHANE, M ; LABOPIN, M ; SHOUTEN, H ; BLAISE, D ; FALDA, M ; FAUSER, A. A ; ESTEVE, J ; POLGE, E ; SLAVIN, S ; NIEDERWIESER, D ; NAGLER, A ; ROCHA, V ; GORIN, N. C ; SHIMONI, A ; RUUTU, T ; KOLB, H.-J ; FRASSONI, F ; BOIRON, J. M ; YIN, J. L ; FINKE, J

London: Nature Publishing

Texto completo disponível

The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients

Ponziani, V ; Gianfaldoni, G ; Mannelli, F ; Leoni, F ; Ciolli, S ; Guglielmelli, P ; Antonioli, E ; Longo, G ; Bosi, A ; Vannucchi, A M

England: Nature Publishing Group

Texto completo disponível

Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden

Vannucchi, A M ; Antonioli, E ; Guglielmelli, P ; Longo, G ; Pancrazzi, A ; Ponziani, V ; Bogani, C ; Ferrini, P R ; Rambaldi, A ; Guerini, V ; Bosi, A ; Barbui, T

England

Texto completo disponível

Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden

VANNUCCHI, A. M ; ANTONIOLI, E ; BOSI, A ; BARBUI, T ; GUGLIELMELLI, P ; LONGO, G ; PANCRAZZ, A ; PONZIANI, V ; BOGANI, C ; ROSSI FERRINI, P. P ; RAMBALDI, A ; GUERINI, V

London: Nature Publishing

Texto completo disponível

Prospective identification of high-risk polycythemia vera patients based on JAK2 super(V617F) allele burden

Vannucchi, A M ; Antonioli, E ; Guglielmelli, P ; Longo, G ; Pancrazzi, A ; Ponziani, V ; Bogani, C ; Ferrini, PR ; Rambaldi, A ; Guerini, V ; Bosi, A ; Barbui, T

Texto completo disponível

No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia

Ponziani, V ; Mannelli, F ; Bartalucci, N ; Gianfaldoni, G ; Leoni, F ; Antonioli, E ; Guglielmelli, P ; Ciolli, S ; Bosi, A ; Vannucchi, A M

England: Nature Publishing Group

Texto completo disponível

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine

Valencia, A ; Masala, E ; Rossi, A ; Martino, A ; Sanna, A ; Buchi, F ; Canzian, F ; Cilloni, D ; Gaidano, V ; Voso, M T ; Kosmider, O ; Fontenay, M ; Gozzini, A ; Bosi, A ; Santini, V

England: Nature Publishing Group

Texto completo disponível

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Vannucchi, A M ; Rotunno, G ; Bartalucci, N ; Raugei, G ; Carrai, V ; Balliu, M ; Mannarelli, C ; Pacilli, A ; Calabresi, L ; Fjerza, R ; Pieri, L ; Bosi, A ; Manfredini, R ; Guglielmelli, P

England: Nature Publishing Group

Texto completo disponível

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

Castagnetti, F ; Gugliotta, G ; Breccia, M ; Stagno, F ; Iurlo, A ; Albano, F ; Abruzzese, E ; Martino, B ; Levato, L ; Intermesoli, T ; Pregno, P ; Rossi, G ; Gherlinzoni, F ; Leoni, P ; Cavazzini, F ; Venturi, C ; Soverini, S ; Testoni, N ; Alimena, G ; Cavo, M ; Martinelli, G ; Pane, F ; Saglio, G ; Rosti, G ; Baccarani, M

England: Nature Publishing Group

Texto completo disponível